Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Also employed in agrochemical research for designing novel pesticides with improved metabolic stability due to the trifluoromethyl group. The compound's scaffold is valuable in medicinal chemistry for optimizing pharmacokinetic properties in drug candidates.